Alex K. Blankenship serves as Executive at AngioSoma, Inc., where they oversee executive responsibilities. Since joining the company, Alex K. Blankenship has executed 9 insider transactions totaling $12.5B, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 14, 2020 involved purchasing 5,000,000 shares valued at $2.5B.
Alex K. Blankenship currently holds 11,000,000 shares of AngioSoma, Inc. (SOAN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alex K. Blankenship has been a net buyer of SOAN stock. They have purchased $12.5B and sold $0 worth of shares.
Alex K. Blankenship's most recent insider trade was on Aug 14, 2020, when they purchased 5,000,000 shares at $500.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 6, 2018 | SOAN | $0 | Purchase | 3,500,000 | $N/A | Discretionary |
| Jul 19, 2017 | SOAN | $4.0B | Purchase | 2,000,000 | $2000.00 | Discretionary |
| Jul 19, 2017 | SOAN | $4.0B | Purchase | 2,000,000 | $2000.00 | Discretionary |
| Apr 17, 2017 | SOAN | $0 | Purchase | 500,000 | $N/A | Discretionary |
| Apr 7, 2017 | SOAN | $0 | Purchase | 500,000 | $N/A | Discretionary |
| Aug 11, 2016 | SOAN | $1.0B | Purchase | 1,000,000 | $1000.00 | Discretionary |
| Aug 11, 2016 | SOAN | $1.0B | Purchase | 1,000,000 | $1000.00 | Discretionary |